Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]
Roivant Sciences (NASDAQ:ROIV) Price Target Cut to $17 00 by Analysts at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Roivant Sciences (NASDAQ:ROIV – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $18.00 to $17.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 54.26% from the company’s […]
Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $16.00 to $15.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts also recently weighed in on ROIV. Truist Financial reissued a buy rating and […]
Roivant Sciences (ROIV) Set to Announce Quarterly Earnings on Monday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.